ID   DKAT-SCGM
AC   CVCL_VQ66
SY   SCGM-DKAT; DKAT-Stromal Cell Growth Media
DR   cancercelllines; CVCL_VQ66
DR   Wikidata; Q93527908
RX   PubMed=23049838;
CC   Group: Serum/protein free medium cell line.
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VQ65 ! DKAT
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 6
//
RX   PubMed=23049838; DOI=10.1371/journal.pone.0045684;
RA   D'Amato N.C., Ostrander J.H., Bowie M.L., Sistrunk C., Borowsky A.D.,
RA   Cardiff R.D., Bell K., Young L.J.T., Simin K., Bachelder R.E.,
RA   Delrow J.J., Dawson A., Yee L.D., Mrozek K., Clay T.M., Osada T.,
RA   Seewaldt V.L.;
RT   "Evidence for phenotypic plasticity in aggressive triple-negative
RT   breast cancer: human biology is recapitulated by a novel model
RT   system.";
RL   PLoS ONE 7:E45684-E45684(2012).
//